Clinical trial · Observational
Adrenal Project: Clinical and Epidemiological Characterization of Adrenocortical Carcinoma in a Brazilian Cohort
NCT06279442CI-TRIAL-00125379completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a retrospective observational cohort study. The clinical, pathological and treatment data of participants identified with adrenocortical carcinoma from the year 2000 onwards will be evaluated. Participants recruited for this study will be identified at the participating sites.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Carcinoma Adrenal | Adrenal Cortical Neoplasm | PROBABILISTIC | 0.70 |
| Carcinoma, Adrenocortical Recurrent | Carcinoma | ONTOLOGY_EXACT | 0.85 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (2)
- measure
- Demographic Characterization of Adrenocortical Carcinoma in Brazil
- timeFrame
- Throughout the study period, an average of 18 months.
- description
- This measure aims to capture essential demographic attributes of individuals in Brazil diagnosed with adrenocortical carcinoma. It will include details such as age distribution in years, gender representation, geographic distribution, height in meters, weight in kilograms, as well as racial and ethnic demographics . These insights will contribute to a comprehensive understanding of the demographic landscape of adrenocortical carcinoma within the Brazilian population.
- measure
- Clinical Characterization of Adrenocortical Carcinoma in Brazil
- timeFrame
- Throughout the study period, an average of 18 months.
- description
- This measure aims to capture essential clinical attributes of individuals in Brazil diagnosed with adrenocortical carcinoma. It will include relevant clinical factors such as tumor stage, hormone secretion status, and treatment modalities. These insights will contribute to a comprehensive understanding of the clinical landscape of adrenocortical carcinoma within the Brazilian population.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Participants over 18 years old; * Diagnosis of adrenocortical carcinoma with at least one clinical evaluation at the reference institution; * Initial diagnosis or recurrence from the year 2000 onwards. Exclusion Criteria: * Participants with insufficient clinical or pathological data in the medical records.
References
Publications (0)
Data not yet available
No reference posted for this study.